Compare GNL & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNL | RXRX |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | N/A | 2021 |
| Metric | GNL | RXRX |
|---|---|---|
| Price | $8.80 | $4.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $9.00 | $8.00 |
| AVG Volume (30 Days) | 1.8M | ★ 23.0M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | ★ 8.62% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $751,333,000.00 | $43,689,000.00 |
| Revenue This Year | N/A | $6.74 |
| Revenue Next Year | N/A | $34.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.63 | N/A |
| 52 Week Low | $6.51 | $3.79 |
| 52 Week High | $8.85 | $12.36 |
| Indicator | GNL | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.17 | 43.62 |
| Support Level | $8.20 | $4.05 |
| Resistance Level | $8.62 | $4.43 |
| Average True Range (ATR) | 0.17 | 0.23 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 90.84 | 15.60 |
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.